• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ON-X LIFE TECHNOLOGIES, INC. ON-X PROSTHETIC AORTIC VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER (ONX; HEART VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ON-X LIFE TECHNOLOGIES, INC. ON-X PROSTHETIC AORTIC VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER (ONX; HEART VALVE, MECHANICAL Back to Search Results
Model Number ONXACE-21
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Insufficient Information (4580)
Date of Event 08/30/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This investigation is currently ongoing.Any additional information will be provided in the follow-up report.This report is being submitted as required by federal regulations and does not constitute an admission that the device caused or contributed to the reported event.Furthermore, this report reflects the event as alleged by the complainant and does not imply that the information reported to artivion is accurate or has been confirmed by artivion.
 
Event or Problem Description
According to the initial notification, "received an aortic irc for a patient with an existing aortic implant.Please let me know if this is an explant." this investigation is relegated to onxace-21, sn (b)(6) with the allegation of explantation.
 
Additional Manufacturer Narrative
Multiple attempts for additional information have gone unmet.No additional information forthcoming.A sample evaluation could not be performed as the device was not returned.The manufacturing records for onxace-21, sn (b)(6) were reviewed.It was confirmed that all records were controlled, available for review, and met all specifications per the device master record.All lots passed functional testing and met release specifications.During the investigation no non-conformance or deviations were found.The available information was reviewed.On 19oct2020 an onxace-21 sn (b)(6) was used in a case for a 36-year-old female in the aortic position.A second aortic on-x was reported to device tracking on 15oct2024 as implanted in the same position, same patient: (b)(6) 2024 onxace-23 sn (b)(6) (1411 post-implant).The patient also received an onxmc 25/33 sn (b)(6) that day.Multiple attempts to receive additional information received no response.Review of manufacturing records show no processing issues with the original valve.The valve was not returned to the manufacturer for examination.We have no information about the explanted on-x valve other than the tracking notice and assume the valve was discarded on site.Consequently, we do not have enough information to know what, if any, contribution the valve had to the decision to replace it.The instructions for use for the on-x valve lists the possibility of explantation as a consequence of a complication of prosthetic heart valve replacement [ifu].But in this instance, we do not have any information to help us identify that complication.There is not enough information to determine what, if any, contribution the on-x valve had to the decision for its removal.No further action is needed without further information.A review of the information was performed to compile a risk analysis.There is not enough information to determine what, if any, contribution the on-x valve had to the decision for its removal.There is insufficient data to determine a product failure mode; thus, severity and occurrence is not evaluated.No further action is required without additional information.A definitive root cause is unknown.There is no indication that an error or deficiency occurred at artivion formerly cryolife and all risks identified have been mitigated as far as possible and residual risk is acceptable; field assurance will continue to monitor similar complaints to determine if additional actions are warranted; however, at this time no further actions are necessary.This report is being submitted as required by federal regulations and does not constitute an admission that the device caused or contributed to the reported event.Furthermore, this report reflects the event as alleged by the complainant and does not imply that the information reported to artivion is accurate or has been confirmed by artivion.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ON-X PROSTHETIC AORTIC VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER (ONX
Common Device Name
HEART VALVE, MECHANICAL
Manufacturer (Section D)
ON-X LIFE TECHNOLOGIES, INC.
1300 east anderson lane
austin TX 78752
Manufacturer (Section G)
ON-X LIFE TECHNOLOGIES, INC.
1300 east anderson lane
austin TX 78752
Manufacturer Contact
rochelle maney
1655 roberts boulevard nw
kennesaw, GA 30144
7704193355
MDR Report Key20620861
Report Number1649833-2024-00070
Device Sequence Number12625823
Product Code LWQ
UDI-Device Identifier00851788001457
UDI-Public00851788001457
Combination Product (Y/N)N
PMA/510(K) Number
P000037
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Device Explanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 01/09/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Expiration Date02/11/2026
Device Model NumberONXACE-21
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/15/2024
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date11/06/2024
Supplement Report FDA Received Date01/09/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured02/11/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other; Hospitalization;
Patient Age40 YR
Patient SexUnknown
-
-